UNSPSC 51372322: Fentanyl hydrochloride

This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H28N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59H156XY46, chemically known as propionanilide, n-(1-phenethyl-4-piperidyl)-, hydrochloride but more generally known as fentanyl hydrochloride, which bears US NIH Compound Identifier 83932. European Medicines Agency schedules Fentanyl hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21234.

Most nations, for tariff and trade purposes, schedule fentanyl hydrochloride under HS 29333300 and SITC 51574. As of Q4 2014, FENTANYL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Fentanyl hydrochloride bears US NLM identifiers UMLS ID C1714006 and NCI Concept Code C61762. SMILES: CCC(=O)N(C1CCCCC1)C2CCN(CC2)CCC3CCCCC3.CL.

UNSPSC 51372322 Fentanyl hydrochloride is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent solicitation recorded under this code—Seminole County, Florida's IFB60459723LAS—targets naloxone and safe drug deactivation systems, not fentanyl hydrochloride itself. Naloxone is an opioid antagonist used to reverse opioid overdose and is functionally unrelated to fentanyl procurement. State and local health and safety agencies do acquire opioid medications and overdose-reversal products, but the recent record under this specific code does not reflect procurement of fentanyl hydrochloride as a pharmaceutical input or controlled substance.

Seminole County's July 2026 IFB sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. The mismatch between the code's nominal scope (fentanyl hydrochloride) and the actual solicitation (naloxone and drug deactivation) suggests either a tagging error in the source data or minimal legitimate procurement activity under this code in the state and local market. No geographic concentration, repeat issuers, or representative recent fentanyl hydrochloride opportunities are supported by the source material. Business development professionals should verify whether fentanyl hydrochloride procurement is regularly tagged under this code in their target jurisdictions before investing pursuit effort.